Cellectar Biosciences, Inc. , an oncology-focused, clinical stage biotechnology company, announces today that President and CEO, Jim Caruso will present at the Biotech Showcase in San Francisco on January 11, 2017 at 10:00 AM PT in Room 2 . “We look forward to discussing the continued advancement of our lead PDC program, CLR 131, as well as providing relevant updates on our other product candidates and corporate performance,” said Mr. Caruso.